Skip to content

Thomas DeLauer Recap: The Yohimbine Fat-Loss Claims, and What to Know First

Takeaways and a chaptered guide to Thomas DeLauer's video on yohimbine and rauwolscine, how fat is released from fat cells, the studies he cites and the safety questions.

By the GNOUP team · · 7 min read

The latest full video on Thomas DeLauer's official YouTube channel, "This Legal Fat Burner Works Better than Any Peptide (safer than steroids)", was posted on November 2, 2026 and runs about 13 minutes. DeLauer, a fitness and nutrition content creator, talks solo about yohimbine, a compound from the bark of an African tree, and rauwolscine, a closely related compound, which he calls among the strongest legal fat burners available. He explains how he thinks they help the body release stored fat, walks through several studies, and acknowledges why they are controversial. Please note that the headline's comparisons to peptides and steroids are the channel's framing, not something the video tests, and that U.S. health authorities have flagged serious safety concerns with yohimbine (see below). These are his opinions and his reading of the research, so treat this as background for a talk with a doctor, not as a plan to follow.

This is an independent summary written by GNOUP. It is not affiliated with, sponsored by or endorsed by Thomas DeLauer, his channel, website or any sponsor. The views and claims described below belong to the speaker, not to GNOUP. This is general information only and is not medical advice. Please talk with a doctor or other qualified healthcare professional before taking any supplement, changing your diet, starting a new exercise program or trying any form of fasting. This matters especially if you have a medical condition (including any heart, blood pressure, anxiety or seizure condition), take any medication, are pregnant or breastfeeding, are under 18, or have a history of an eating disorder. GNOUP has no connection to any product, supplement, brand or paid offer mentioned in or around the video and does not promote any of them.

Key health tips and takeaways

These are ideas DeLauer shared in the video, not instructions. GNOUP has deliberately left out every dose, timing and "how to take it" suggestion from the video.

  • Releasing fat is not the same as burning it. DeLauer's most practical point is that, in his view, yohimbine helps free fat from storage into the bloodstream (mobilization) but does not by itself burn it. He says taking it while sitting at a desk would do little, and he ties any benefit to being active. The broader idea that stored fat has to be both released and then used for energy is a general one that applies to any fat-loss approach.
  • How fat gets released, as he explains it. He walks through the body's signaling chain: stress hormones such as norepinephrine (noradrenaline), released during hard exercise, for example, bind to receptors on fat cells and set off a chain of enzymes that breaks stored fat (triglycerides) into fatty acids and glycerol. He says a different set of receptors on fat cells, called alpha-2 receptors, act like a brake on that process.
  • Why he thinks yohimbine works. In his view, yohimbine blocks those alpha-2 "brake" receptors and also raises norepinephrine, giving what he describes as three separate routes to more fat release. He presents rauwolscine as a more refined version that he believes may cause fewer jitters; GNOUP has not checked that claim.
  • Appetite. DeLauer says that when more fat is circulating in the blood, the brain senses that fuel is available, and that this is why he finds these compounds suppress appetite. This is his explanation, not an established fact.
  • He names the downside himself. DeLauer says yohimbine strongly activates the body's "fight or flight" system, so people prone to stress, anxiety or jitteriness may feel worse on it. Independent health sources go further, as described in the next section.

Newsworthy insights

These are claims and opinions from the video. GNOUP has not verified them, and experts may disagree with parts of them.

  • The human study he leads with. DeLauer cites a study in Research in Sports Medicine. Its PubMed abstract (Ostojic, 2006) describes 20 professional male soccer players given yohimbine or a placebo for 21 days. Body fat percentage fell in the yohimbine group, from about 9.3% to about 7.1%, with no significant change in body weight, muscle mass or performance tests, and no side effects reported. In the video DeLauer describes this as a "7.1% decrease" in body fat; per the abstract, 7.1% was the group's ending body fat percentage, a drop of roughly two percentage points. It was a small, short study in young elite athletes, so the results may not apply to other people.
  • Lab and older studies. He also cites a 1988 study in the European Journal of Clinical Investigation (Galitzky and colleagues) on healthy male volunteers, which by its title found a fat-mobilizing effect of oral yohimbine, plus a sports-nutrition study, a Medical Hypotheses paper and a rodent study in the Journal of Biological Chemistry that he says linked more alpha-2 receptors with more fat storage. He suggests this means blocking them could help prevent fat gain; that is his extrapolation from animal work.
  • What U.S. health officials say. The National Institutes of Health's complementary health center (NCCIH) says there is not enough research to say whether yohimbe supplements help with obesity or athletic performance. Its yohimbe fact sheet says yohimbine has been associated with irregular heartbeat, blood pressure problems, heart attacks and seizures, that yohimbe can interact with some antidepressants, that products often don't state how much yohimbine they contain, that supplements have been restricted or banned in many countries, and that it may be unsafe during pregnancy or breastfeeding.
  • His fasting angle. DeLauer argues the effect is strongest when combined with exercise or fasting. GNOUP has left out his specific suggestions; fasting and stimulant-type supplements together can be risky, so ask a doctor first.
  • The headline. The title calls it "safer than steroids" and better than "any peptide." The video does not compare it with peptides or steroids in any study, so read the headline as the channel's opinion.

Watch the video

This Legal Fat Burner Works Better than Any Peptide (safer than steroids) on YouTube (official channel "Thomas DeLauer," @ThomasDeLauerOfficial, published November 2, 2026, about 12 minutes 44 seconds)

Episode guide

These chapters come from the video's own description (titles lightly reworded). Each link opens the video at that point.

About this summary

This recap was prepared from the video's title, description and chapter list, the channel page, and a transcript of the video. We looked up the main human study on PubMed and checked its design and results as stated in the abstract, confirmed the titles of the 1988 study, and drew the safety information from the NCCIH yohimbe fact sheet; we did not review the full papers. We left out the sponsor segment, product names, discount codes, all supplement doses and timing, and fasting suggestions. Transcripts can contain errors, so for the exact words and context, watch the video. This article is general information, not medical advice, and is not a substitute for guidance from a qualified healthcare professional.